Gain Therapeutics, Inc.

Direct answer

Gain Therapeutics, Inc. is publicly traded on NASDAQ under the ticker GANX.

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed proteins. Subsequently,...

Can you invest in Gain Therapeutics, Inc.?

Yes. Gain Therapeutics, Inc. is publicly traded on NASDAQ under the ticker GANX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Gain Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.